Autologous arteriovenous access is the key to long-term success with hemodialysis and is strongly supported by the National Kidney Foundation's Dialysis Outcomes Quality Initiative guidelines. Basilic ...

Please provide your email address to receive an email when new articles are posted on . Before the pandemic, 34.5% of patients with disabilities and end-stage kidney disease transitioned to home ...

The University of Alabama at Birmingham (UAB) Kidney-Pancreas Transplant faculty have busy elective dialysis access practices. Almost 1,000 operative cases are performed each year. A strong emphasis ...

Patients with kidney failure must often have hemodialysis one or more times each week to assist their kidneys in filtering waste products out of their blood streams. The dialysis filtering process ...

The LifeSite Hemodialysis System (Vasca, Inc., Tewksbury, MA, USA)is totally subcutaneous, incorporating two silicone catheters positioned in the central venous system and connected to a stainless ...

A heparin-coated endovascular prosthesis has received approval from the US Food and Drug Administration (FDA) for treatment of stenosis or thrombotic occlusions at the venous anastomosis of synthetic ...

DURHAM, N.C., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

Dialysis can be provided thrice weekly in a center specifically for this purpose or at home. Most patients in the US dialyze in-center despite the benefits of home dialysis and the potential for ...

The FDA has cleared catheter-based vascular access systems for sale. Both devices enable physicians to create arteriovenous (AV) fistulas through the skin, thereby simplifying a vital preparatory step ...

Despite all the progress achieved since Scribner first introduced the arteriovenous (AV) shunt in 1960 and Cimino and Brescia introduced the native AV fistula in 1962, we have continued to face a ...